Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Oncology Institute (TOI) Return on Invested Capital (2021 - 2025)

Historic Return on Invested Capital for Oncology Institute (TOI) over the last 5 years, with Q3 2025 value amounting to 0.63%.

  • Oncology Institute's Return on Invested Capital fell 700.0% to 0.63% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.63%, marking a year-over-year decrease of 700.0%. This contributed to the annual value of 0.44% for FY2023, which is 13300.0% down from last year.
  • Latest data reveals that Oncology Institute reported Return on Invested Capital of 0.63% as of Q3 2025, which was down 700.0% from 0.65% recorded in Q2 2025.
  • In the past 5 years, Oncology Institute's Return on Invested Capital ranged from a high of 0.67% in Q4 2022 and a low of 0.65% during Q2 2025
  • Over the past 5 years, Oncology Institute's median Return on Invested Capital value was 0.51% (recorded in 2023), while the average stood at 0.31%.
  • Per our database at Business Quant, Oncology Institute's Return on Invested Capital soared by 12400bps in 2022 and then tumbled by -11800bps in 2023.
  • Over the past 5 years, Oncology Institute's Return on Invested Capital (Quarter) stood at 0.57% in 2021, then skyrocketed by 217bps to 0.67% in 2022, then crashed by -177bps to 0.51% in 2023, then dropped by -9bps to 0.56% in 2024, then dropped by -13bps to 0.63% in 2025.
  • Its last three reported values are 0.63% in Q3 2025, 0.65% for Q2 2025, and 0.56% during Q3 2024.